← Back to Search

LASIK

Contoura with Phorcides and WaveLight Wavefront Optimized for Near-sightedness and Astigmatism

N/A
Recruiting
Research Sponsored by Daniel Terveen
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months post-op
Awards & highlights
No Placebo-Only Group

Summary

This trial compares two laser eye surgery techniques in patients looking to improve their vision. Both methods use lasers to reshape the cornea, enhancing visual clarity and patient satisfaction. One of the methods used in this trial has been shown to provide excellent visual outcomes.

Eligible Conditions
  • Near-sightedness
  • Astigmatism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post-op
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post-op for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Post-Op UDVA
Secondary study objectives
Corrected Distance Visual Acuity
Low Contrast Visual Acuity
Post-OP BCVA
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Study: PhorcidesExperimental Treatment1 Intervention
Contoura with Phorcides used for surgical planning of LASIK procedure
Group II: Control: Wavefront OptimizedActive Control1 Intervention
WaveLight Wavefront Optimized used for surgical planning of LASIK procedure

Find a Location

Who is running the clinical trial?

Daniel TerveenLead Sponsor
Alcon ResearchIndustry Sponsor
732 Previous Clinical Trials
128,739 Total Patients Enrolled

Media Library

Contoura with Phorcides (LASIK) Clinical Trial Eligibility Overview. Trial Name: NCT05486546 — N/A
Near-sightedness Research Study Groups: Control: Wavefront Optimized, Study: Phorcides
Near-sightedness Clinical Trial 2023: Contoura with Phorcides Highlights & Side Effects. Trial Name: NCT05486546 — N/A
Contoura with Phorcides (LASIK) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05486546 — N/A
~36 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top